2nd Circ. Actos Ruling Boosts Pharma Antitrust Plaintiffs
The Second Circuit has revived claims by purchasers of diabetes drug Actos accusing Takeda of delaying generic competition for the drug, providing guidance on antitrust causation in a ruling that smooths...To view the full article, register now.
Already a subscriber? Click here to view full article